[Converting enzyme inhibitors in the therapy of primary arterial hypertension].
作者信息
Di Veroli C, Bossini A, Amoroso A
出版信息
Recenti Prog Med. 1985 May;76(5):269-71.
PMID:2992055
Abstract
摘要
相似文献
1
[Converting enzyme inhibitors in the therapy of primary arterial hypertension].[转换酶抑制剂在原发性动脉高血压治疗中的应用]
Recenti Prog Med. 1985 May;76(5):269-71.
2
[Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Wiad Lek. 1984 May 15;37(10):792-6.
3
Resolution of captopril-induced rash after substitution of enalapril.
Pharmacotherapy. 1983 Mar-Apr;3(2 Pt 1):131-3.
4
Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.卡托普利和依那普利：血管紧张素转换酶（ACE）抑制剂。
Ration Drug Ther. 1984 Mar;18(3):1-5.
5
Enalapril treatment in a patient with impaired renal function and intolerance to captopril.依那普利治疗肾功能受损且对卡托普利不耐受的患者。
Scand J Urol Nephrol Suppl. 1984;79:99-101.
6
Converting enzyme inhibitors in hemodialysis.血液透析中的转化酶抑制剂
Int J Artif Organs. 1983 Mar;6(2):62-4.
7
Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.三种结构不同的血管紧张素转换酶抑制剂（卡托普利、SA - 446和MK - 421）对血压、肾素 - 血管紧张素系统和激肽释放酶 - 激肽系统急性作用的比较。
Nihon Jinzo Gakkai Shi. 1985 Mar;27(3):337-42.
8
Angiotensin-converting enzyme inhibitors: past, present, and bright future.血管紧张素转换酶抑制剂：过去、现在与光明未来。
Lancet. 1985 Jan 5;1(8419):30-4. doi: 10.1016/s0140-6736(85)90975-4.
9
Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
Adv Nephrol Necker Hosp. 1981;10:111-33.
Zotero 插件